New consensus treatment plans state that the combination of glucocorticoids and immunosuppression is treatment of choice for newly diagnosed pediatric patients with proliferative lupus nephritis. However, variations exist in the steroid protocol and in the type of immunosuppressant used, indicating that a gold-standard treatment protocol is yet to be achieved.